Zhonghua Nan Ke Xue. 2024 Nov;30(11):1009-1014.
ABSTRACT
OBJECTIVE: To explore the clinical effect of hernia needle combined with single-port laparoscopy-assisted transscrotal orchidopexy (HN-SLATO) in the treatment of mid-low cryptorchidism in children.
METHODS: We selected 80 children with mid-low congenital cryptorchidism treated from January 2023 to January 2024, and equally randomized them into an observation and a control group to receive HN-SLATO and conventional laparoscopic orchidopexy (LO), respectively. We recorded the surgical parameters, the postoperative scores of the patients’ on the Face-Legs-Activity-Crying-Consolability Scale (FLACC) and Vancouver Scar Scale (VSS), the serological indicators of interleukin-6 (IL-6), inhibitor B (INH-B) and high-sensitivity C-reactive protein (hsCRP), and the incidence of postoperative complications at 1 month after surgery between two groups, followed by comparison between the two groups.
RESULTS: The total effectiveness rate of treatment was significantly higher in the observation than in the control group (97.5% vs 75.0%, P<0.05), and so was the success rate of testicular descent (100% vs 85.0%, P<0.05), but there was no significant difference in surgical time and postoperative hospital stay between the two groups (P > 0.05). The VSS score was remarkably lower in the former than in the latter group (3.3 ± 0.9 vs 4.3 ± 1.0, P<0.05). The FLACC scores were markedly increased in both the observation and control groups at 24 hours (3.6 ± 0.2 and 4.1 ± 0.3) and 72 hours (3.0 ± 0.3 and 3.5 ± 0.2) compared with those at 2 hours after surgery (2.2 ± 0.2 and 2.3 ± 0.1) (P<0.05), but less increased in the former group than in the latter (P<0.05). The postoperative levels of IL-6, INH-B, and hsCRP were all significantly elevated compared with the baseline in both groups, but less significantly in IL-6 and hsCRP in the observation than in the control group (P<0.05). The incidence of postoperative complications was dramatically lower in the former group than in the latter (2.5% vs 20.0%, P<0.01).
CONCLUSION: HN-SLATO has a significant clinical efficiency and high safety in the treatment of mid-low cryptorchidism in children, which can effectively improve intraoperative fixation and postoperative aesthetics of the testis, as well as reduce pain, serum inflammatory indicators and postoperative complications.
PMID:40783870
